D - Description
Quality
Management |
Training and
Education |
Public
Involvement |
Description | |
---|---|
Name |
PEDSTART - French national paediatric research network |
Year of foundation | Founded in 2018 PEDSTART is the French contribution to c4c hosted by the INSERM in 2018. Even if PEDSTART network is a young network, it is based on the French paediatric CICs (Clinical Investigation Centers) network since 2005 (former member of EnprEMA) |
Preterm and/or term newborn | Yes |
Infants from 1 month to less than 24 months of age | Yes |
Children from 2 years to less than 12 years of age | Yes |
Adolescents from 12 years to less than 18 years | Yes |
Paediatric age ranges of study participants covered by the network | 0-18 years |
Multispeciality? Specify | Nutrition, Rare diseases, Pharmacology Modelisation, PK, Pain management, pharmacovigilance |
Speciality/disease specific? Specify | |
Conditions covered? Specify | All conditions covered by specialties and subspecialties |
Procedure/Intervention specific? Specify | All procedures/interventions |
Number of collaborating countries | 1 |
List of collaborating countries | France |
Number of collaborating centres | 21 |
List of collaborating centres | -18 Nationwide Clinical Investigation Centers (CICs) affiliated to INSERM and University hospitals (Amiens, Bordeaux, Brest, Caen, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Paris-Necker, Paris Robert-Debré, Paris Kremlin-Bicêtre, Rennes, Rouen, Toulouse,) - 2 paediatric clinical research networks: HUGOPEREN which is the Pediatric Research Network in the University Hospitals of western France and RIPPS which is the Paediatric Investigation Network of health products - 1 medical-social institution : ESEAN |
Type of activity/studies | |
Clinical Studies | Yes |
Experimental research | Yes |
Other activity | • Designing paediatric clinical trials • Feasibility studies • Expert group support • Support for research project design and development • Staff development training courses Participation in the european YPAG (Young Patients Advisory Group) |